Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1003464 on January 14, 2004

Published online before print January 14, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1003464v1
75/4/664    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, S.
Right arrow Articles by Schmid-Schönbein, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, S.
Right arrow Articles by Schmid-Schönbein, G. W.
(Journal of Leukocyte Biology. 2004;75:664-670.)
© 2004 by Society for Leukocyte Biology

Leukocyte fluid shear response in the presence of glucocorticoid

Shunichi Fukuda*, Hiroshi Mitsuoka{dagger} and Geert W. Schmid-Schönbein*,1

* Department of Bioengineering and The Whitaker Institute of Biomedical Engineering, University of California San Diego, La Jolla, California; and
{dagger} Second Department of Surgery, Hamamatsu University School of Medicine, Japan

1Correspondence: Department of Bioengineering, The Whitaker Institute of Biomedical Engineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0412. E-mail: gwss{at}bioeng.ucsd.edu


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Leukocytes respond to physiological fluid shear stress (~1.5 dyn/cm2) by cytoplasmic reorganization. The cytoplasm is also influenced, however, by glucocorticoids. In this study, we explore how glucocorticoids may affect the leukocyte fluid shear response. Normal leukocytes, exposed to fluid shear in vitro during active migration, retract pseudopods accompanied by modestly decreasing intracellular calcium ions. In contrast, dexamethasone (DX)-treated leukocytes project pseudopods after shear exposure with a significant rise in intracellular calcium ions, an effect that can be blocked by voltage-dependent calcium channel blockers. Although a cyclic adenine monophosphate analog blocks calcium influx and pseudopod projection by DX, inhibition of A-kinase induces reversal of the shear response, as seen with DX treatment. DX also reverses the leukocyte shear response in vivo in the rat circulation. Leukocytes that adhere to the endothelium in postcapillary venules of control rats return into the circulation only after pseudopod retraction, and in DX-treated rats, adherent leukocytes return into the circulation still with projecting pseudopods. The fraction of circulating leukocytes with pseudopods in DX-treated rats is higher than in controls. Thus, the reversal of leukocyte shear response by glucocorticoids may contribute to an enhanced incidence of circulating leukocytes with pseudopods, a process that affects the kinetics of these cells in the microcirculation.

Key Words: mechanotransduction • fluid shear stress • pseudopod formation


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
When physiological fluid shear stress (~1.5 dyn/cm2) is applied to the membrane of fresh human leukocytes (neutrophils, monocytes, and lymphocytes) during migration on a surface, they respond within minutes by retraction of pseudopods as a result of actin depolymerization [1 2 3 ]. Rat leukocytes suspended in whole blood also respond to fluid shear in a cone-and-plate shear device (~5 dyn/cm2) by pseudopod retraction [2 , 3 ]. Inflammatory mediators, such as platelet activating factor (PAF) and f-Met-Leu-Phe (fMLP), suppress the shear response of leukocytes, and nitric oxide derived from endothelial cells enhances the shear response via a cyclic guanosine monophosphate pathway [2 ]. The shear stress response of leukocytes serves as a key mechanism to maintain circulatory leukocytes in a spherical shape without pseudopod formation. In the presence of pseudopods, leukocytes become trapped in capillaries [4 ]. Thus, an elevated number of leukocytes with pseudopods as a result of an attenuated shear response may compromise normal passage of leukocytes through capillaries.

Glucocorticoids have several anti-inflammatory activities [5 , 6 ]. The effect of glucocorticoids, however, on the fluid shear response is unexplored. We present a sequence of in vivo and in vitro studies designed to explore several mechanisms underlying the reversed fluid shear response in glucocorticoid-treated leukocytes. The evidence indicates that glucocorticoids reverse the normal leukocyte shear response; i.e., during shear exposure, they exhibit pseudopod projection instead of retraction.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
As centrifugation interferes with the shear response [3 ], 1 g sedimentation or when possible, whole blood without separation of leukocytes was used.

Shear response of adherent leukocytes
Erythrocytes in fresh blood from volunteers (30 U/ml ammonium heparin as anticoagulant) were separated by 1 g sedimentation. Aliquots of the supernatant with leukocytes were resuspended in buffer containing Plasma-Lyte (1:20, Baxter Health Care, Deerfield, IL; with 2.5 mM Ca2+), incubated with 1 µM Indo-1 AM (Molecular Probes, Eugene, OR) at 37°C for 30 min, and placed on a cover glass. After 15 min, the cover glass was gently rinsed with the buffer, and adherent leukocytes on the glass were observed with an inverted laser confocal microscope (MRC 1024, Bio-Rad Laboratories, Hercules, CA) with 60x objective (NA=1.4). The 410/490 nm emission ratio and transmission image were recorded. Using a calcium calibration buffer kit (Molecular Probes), the absolute values of intracellular-free calcium levels, [Ca2+]i, were computed using the Grynkiewicz equation. [7 ].

Micropipettes with tip diameter between 4 and 6 µm were positioned adjacent to individual neutrophils so that a fluid flow could be applied over the cell membrane. The pipettes were filled with the same buffer in which the cells were suspended. The flow rate out of the pipette was adjusted by hydrostatic pressure inside the pipette, and in pilot studies, the peak (midstream) velocity at each pressure was measured by tracing the microsphere (~0.2 µm diameter) positions [1 ]. The magnitude of fluid stress was numerically computed for exactly the same setup (including size of cell, pipette, position of the pipette) by solution of the Stokes approximation of the equation of motion for a Newtonian fluid (plasma, 1.2 centipoise) and use of a finite element method [1 ]. This computation shows that the flow field over the surface of the cell yields a spatially nonuniform shear stress. A peak shear stress of ~1.5 dyn/cm2 is present on the upstream side of the cell close to the pipette; on the opposite, down-stream side, the shear stress is close to zero [1 ].

As a measure for the degree of cell extension as a result of pseudopod formation, the maximum length across the cell (L) was measured and normalized by cell diameter without pseudopods (L0; Fig. 1 ).



View larger version (113K):
[in this window]
[in a new window]
 
Figure 1. Micrographs of human neutrophils adherent to glass surface before and during shear exposure (1.5 dyn/cm2). Left column shows control; right column, 1 µM dexamethasone (DX)-treated cell before (A, E) or 60 s (B, F) and 120 s after (C, G) application and 60 s after cessation (D, H) of fluid shear produced by flow from a micropipette (arrows). In the left row, the cell exhibits normal pseudopod retraction and on the right, pseudopod projection during fluid shear application. L, Maximum cell length; L0, diameter close to the spherical state.

 
Animals
The femoral veins and arteries of mature male Wistar rats (n=30, 300–380 g) were cannulated under general anesthesia (sodium-pentobarbital, 50 mg/kg). The experimental protocol was reviewed and approved by the University of California San Diego Animal Subjects Committee (La Jolla).

Shear response of leukocytes in suspension
Eighteen animals were used for the experiments. PAF, fMLP, DX, diltiazem, nifedipine, and 8-bromoadenosine 3',5'-cyclic monophosphate (8-br-cAMP; all from Sigma Chemical Co., St Louis, MO), R-p-bromoadenosine 3',5'-cyclic monophosphorothioate (Rp-8-b-cAMPS; Life Science, San Diego, CA), or physiological saline were applied 30-min after arterial blood collection (30 U/ml ammonium heparin). Fifty minutes after blood collection, whole blood (0.3 ml) was sheared in the cone-and-plate device (5.0 dyn/cm2 for 10 min) [2 ] and immediately fixed with 2% glutaraldehyde. Unsheared samples were fixed at the same time and analyzed in parallel with the sheared samples. After staining with 0.02% crystal violet, the fraction of leukocytes with pseudopods was counted in a blinded manner.

Fraction of circulating leukocytes with pseudopods in arterial blood
Femoral arterial blood (0.3 ml) was collected with 30 U/ml ammonium heparin from eight control rats and eight rats treated with 0.5 mg/kg/day (intramuscularly) for 7 days (DX-treated rats). The cells were immediately fixed with 2% glutaraldehyde, and the fraction of leukocytes with pseudopods was counted in the same way as explained above.

Shear response of leukocytes adhering to postcapillary venules in the microcirculation
The ileocecal portion of the mesentery of four control Wistar rats and four DX-treated rats (0.5 mg/kg/day for 7 days) was exteriorized. The tissue was carefully draped over a pedestal and superfused with a Krebs-Henseleit bicarbonate-buffered solution saturated with a 95% N2 and 5% CO2 mixture (36.5°C, pH 7.4). The mesenteric microcirculation was visualized with an intravital microscope (Leitz) through a 25x water immersion objective (Zeiss, NA=0.6) using a color CCD television camera (Optonics) and a Halogen light source with heat filter [1 2 3 ]. fMLP (10 nM) was applied on the mesentery by superfusion 30 min before the experiment. To temporarily reduce fluid shear stress to near-zero values, one of the outflow postcapillary venules was occluded for 3 min with a blunt micropipette [1 , 2 ]. Pseudopod formation on individual leukocytes downstream of the occlusion site was observed during stoppage and after flow restoration.

Statistics
Measurements are presented as mean ± SD. The data in Figure 2F were analyzed using {chi}2 test. Differences between groups in other experimental data were analyzed by ANOVA and Fischer’s protected least significant difference test. The number of observations is indicated in the figure legends. P < 0.05 was considered to be significant.



View larger version (53K):
[in this window]
[in a new window]
 
Figure 2. Shear response of adherent leukocytes. (A–E) Time course of intracellular calcium level (nM; • and {blacktriangleup}, left Y axis) and pseudopod formation (L/L0; {circ} and {triangleup}, right Y axis) in human neutrophils. (A) Control (• and {circ}) and 1 µM DX ({blacktriangleup} and {triangleup}); (B) DX with 75 µM diltiazem (• and {circ}); (C) DX with 100 µM 8-br-cAMP (• and {circ}); (D) 80 mM KCl (• and {circ}); (E) L/L0 under 100 µM Rp-8-b-cAMPS with (•) or without ({circ}) diltiazem. The fluid shear stress is ~1.5 dyn/cm2 (30–150 s). n = 6 cells in each case. *, Versus control (A), Rp-cAMPS (E; P<0.05). (F) Fraction of neutrophils responding to shear (1.5 dyn/cm2) at different levels of DX without ({circ}) or with 10 µM PAF (x) or 10 µM fMLP ({square}). n = 10 cells in each case. Responding leukocytes are defined as the cells in which more than a 20% reduction of L/L0 is observed during a 2-min shearing period. *, #, **, Versus values without DX treatment (0 µM) in DX, DX with PAF, and DX with fMLP, respectively (P<0.05, {chi}2).

 

    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Shear response of individual adherent leukocytes in vitro
Before shear exposure, the majority of leukocytes projected and retracted pseudopods in a period pattern. During shear application, the cells retracted their pseudopods and assumed almost spherical shapes (Figs . 1A 1B 1C and 2A) .

In contrast, after DX treatment, pseudopod formation without shearing was less than in controls (Fig. 1E) , and after fluid shear exposure, leukocytes continued to project pseudopods and even spread (Fig . 1F 1G 1H and 2A) .

Pseudopod formation and [Ca2+]i
In control neutrophils, the [Ca2+]i insignificantly decreased during fluid shear in association with pseudopod retraction (Fig. 2A) . However, after DX treatment, the [Ca2+]isignificantly increased in parallel with pseudopod projection during shear exposure (Fig. 2A) . The calcium channel blocker, diltiazem, as well as the cAMP analog, 8-br-cAMP, almost completely inhibited the [Ca2+]i increase and pseudopod projection (Fig . 2B and 2C) .

Treatment with 80 mM K+ had a similar influence on shear response as DX treatment (Fig. 2D) . The A-kinase inhibitor, Rp-8-b-cAMPS, also led to pseudopod projection and to an intracellular calcium increase (data not shown) after shear application, which diltiazem inhibited (Fig. 2E) . In the absence of shear stress, treatment with Rp-cAMPS caused leukocytes to remain in an almost spherical shape. In all groups, shear-induced pseudopod projection was consistently accompanied by a [Ca2+]i rise. The reversed shear response by DX was dose-dependent and observed regardless of the choice of the inflammatory stimulator (Fig. 2F) . Although in the absence of DX, 100% of leukocytes responded to shear application, in the presence of 0.1 µM DX, only 60% of leukocytes responded to shear exposure.

Shear response of circulating leukocytes after DX treatment
In the cone-and-plate device, the fraction of leukocytes with pseudopods in controls (n=5 animals) was lower after shear exposure, and with DX treatment (n=5 animals), the fraction was significantly higher after shear (Fig. 3A ). In the presence of inflammatory stimulators, the fraction was increased, and DX treatment served to impair the shear response.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Fraction of leukocytes with pseudopods in rat whole blood without and with fluid shear stress (5.0 dyn/cm2). (A) Control ({circ}); 10 µM DX (•); 10 nM PAF ({triangleup}); DX and PAF ({blacktriangleup}); 10 nM fMLP ({diamond}); DX and fMLP ({diamondsuit}). (B) Control ({circ}); DX (•); 75 µM diltiazem ({square}); DX and diltiazem ({blacksquare}); 100 µM nifedipine ({triangleup}); DX and nifedipine ({blacktriangleup}). (C) Control ({circ}); DX (•); 100 µM 8-br-cAMP ({triangleup}); DX and 8-br-cAMP ({blacktriangleup}); 100 µM Rp-8-br-cAMPS (x). n = 5 samples from five animals in each case. *, Versus control (A–C; P<0.001); #, versus fMLP (A; P=0.0041), DX (C; P<0.001); **, versus PAF (A; P<0.001).

 
Diltiazem, nifedipine (a calcium antagonist), and 8-br-cAMP attenuated the DX-induced pseudopod projection under fluid shear, and these agents had no significant effect in controls (Fig . 3B and 3C , n=5 animals in each). Rp-8-b-cAMPS treatment produced pseudopods during shear exposure, as seen with DX treatment.

Shear response in DX-treated rats
The fraction of circulating leukocytes with pseudopods in arterial blood of controls was 5.1 ± 2.0% (n=8), and that in DX-treated rats (0.5 mg/kg/day for 7 days) was 41.0 ± 6.5% (n=8, Figs . 4 and 5A ).



View larger version (120K):
[in this window]
[in a new window]
 
Figure 4. Sample micrographs of pseudopod formation of rat leukocytes in arterial blood. (A) A control rat; (B) a DX-treated rat (0.5 mg/kg/day for 7 days). Blood was fixed immediately after collection, and erythrocytes were removed by fluorescein-activated cell sorter lysing solution, a procedure that does not affect pseudopods in leukocytes after fixation. Note the enhanced number of leukocytes with pseudopod in DX-treated rats.

 


View larger version (18K):
[in this window]
[in a new window]
 
Figure 5. Leukocyte kinetics in the rat circulation. (A) Fraction of leukocytes with pseudopods in arterial blood. n = 8 rats in each; P < 0.0001. (B) Time course of pseudopod formation of leukocytes measured in terms of the length ratio L/L0 in rat mesentery venules during obstruction (O) and after flow restoration (R). Only cells were selected that detached from the vessel wall within 10 s after flow restoration. Controls ({circ}); DX-treated rats (0.5 mg/kg/day for 7 days; x). n = 8 cells in four animals each. *, Versus the value of controls just after flow obstruction (at time –80 s; P<0.05); #, versus the value of DX-treated rats just before flow restoration (at time 0 s; P<0.05).

 
Leukocyte kinetics in rat postcapillary venules
In control rats (n=4) during topical application of fMLP, most of the leukocytes (seven of eight cells) were almost spherical when blood flow was obstructed. All leukocytes during stasis adhered to the vessel wall and projected pseudopods. Seventy-five percent of leukocytes retracted pseudopods shortly after restoration of blood flow and were washed away in the blood stream once they had reached an almost spherical cell shape (Fig. 5B) . After flow restoration, 25% of the leukocytes continued to adhere to the endothelium with pseudopods at least for 2 min.

In contrast, in DX-treated rats (n=4, 0.5 mg/kg/day for 7 days) during topical application of fMLP, pseudopod formation was observed in 63% of leukocytes when blood flow was obstructed. During flow obstruction, fewer leukocytes (25%) adhered to the endothelium, and shorter pseudopods were projected (Fig. 5B) . Some leukocytes (25%) even retracted pseudopods. After flow restoration, all leukocytes continued to project pseudopods but were less adhesive and washed away in the blood stream.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Effect of glucocorticoids on shear response of leukocytes
The typical magnitude of physiological fluid shear stresses in the microcirculation is 1–10 dyn/cm2. The shear stress response of leukocytes is seen at these levels of shear stress [1 2 3 ]. The current evidence indicates that glucocorticoid reverses the leukocyte shear response under all conditions we have examined. This includes individual human adherent leukocytes at 1.5 dyn/cm2 (Figs. 1 and 2A and 2F) , rat leukocytes in whole blood suspension at 5.0 dyn/cm2 in vitro (Fig. 3A) , rat circulating leukocytes (Figs. 4 and 5A) , and activated leukocytes on vascular endothelium in the rat mesenteric microcirculation in vivo (Fig. 5B) . Control leukocytes actively migrate on a glass surface and instantly retract pseudopods when exposed to fluid shear. In contrast, adherent DX-treated leukocytes after shear exposure project pseudopods and even spread out, and without fluid shear, they project fewer pseudopods than controls.

In postcapillary venules of DX-treated rats, leukocytes continue to project pseudopods after flow restoration but are less adhesive and washed away in the blood stream (Fig. 5B) . Leukocyte transmigration, but not rolling or adhesion, is inhibited by DX in the inflamed hamster post-capillary venule [8 ]. With DX treatment, about two-thirds of adherent leukocytes become detached under normal flow conditions and returned to the blood stream, and transmigration requires a significantly longer period compared with controls [8 ]. These observations are consistent with the current in vivo data.

Mechanisms for reversed shear response by glucocorticoids
As the reversal of shear response was observed, even 20 min after DX treatment in vitro (Fig. 3A) , the effect appears to require no new protein synthesis and instead, may be a direct, nongenomic effect on the plasma membrane. Glucocorticoids bind receptors on the cell surface and alter membrane ion permeability [9 ]. Under the influence of shear stress, pseudopod projection on DX-treated leukocytes is accompanied by an increase in intracellular-free calcium level, and in untreated leukocytes, neither pseudopod projection nor a rise of calcium level is observed (Fig. 2A) . The evidence suggests that the rise in intracellular calcium level during shear application as a result of glucocorticoids is closely associated with pseudopod projection.

Glucocorticoids modulate voltage-dependent Ca2+ channels [10 ]. Voltage-dependent Ca2+ channel blockers inhibit the ability of DX to induce pseudopod projection as well as an increase in cytoplasmic-free Ca2+ with shear application (Figs. 2B and 3B) . Moreover, after membrane depolarization by a high concentration of potassium ion, which serves to open voltage-dependent Ca2+ channels, pseudopod projection and a calcium rise were observed only during shear application, similar to the situation after DX treatment (Fig. 2D) . Shear-induced pseudopod projection in the presence of DX may be closely associated with calcium influx through voltage-dependent and shear-sensitive Ca2+ channels.

Shear-induced [Ca2+]i elevation and pseudopod projection as a result of DX were attenuated by a cAMP analog (Figs. 2C and 3C) . There are several mechanisms by which cAMP may act, such as activation of calcium pumps and inactivation of phospholipase C [11 ]. Another possibility is that cAMP may be associated with closure of a voltage-dependent and shear-sensitive Ca2+ channel via A-kinases. Several voltage-dependent Ca2+ channels are regulated by A-kinases, such that they have a stimulatory or an inhibitory effect on channel opening [12 ]. The A-kinase inhibitor, Rp-8-b-cAMPS, reverses the shear response and increases [Ca2+]i only during fluid shear application. This reversed shear response by Rp-8-b-cAMPS was also inhibited by diltiazem (Figs. 2E and 3C) . Therefore, A-kinase may have an inhibitory effect on opening the voltage-dependent, shear-sensitive Ca2+ channel so that glucocorticoid suppresses channel closure by A-kinase. It is interesting that in goldfish melanocytoma, DX induces cell spreading, which is inhibited by 8-br-cAMP or nifedipine [13 ].

Microvascular consequences of reversed leukocyte shear response by glucocorticoids
Glucocorticoids attenuate leukocyte activation and leukocyte-endothelial cell interaction by reduction of adhesion molecule expression [5 , 6 ]. These actions may contribute to inhibition of leukocyte adhesion and emigration in postcapillary venules in inflammation (Fig. 5B) . Generally, activated leukocytes increase their adhesion molecule expression on the membrane along with enhanced pseudopod formation. However, in the presence of fluid shear, glucocorticoids may cause dissociation between reduced expression of adhesion molecules and enhanced pseudopod formation. Reduced adhesion of leukocytes on venular endothelium and pseudopod projection under blood flow as a result of DX may contribute to the elevated fraction of leukocytes with pseudopods in the circulation (Figs. 4 and 5A) . The evidence in turn clearly shows the importance of the leukocyte shear response to keep circulating leukocytes in a spherical state.

A high incidence of leukocytes with pseudopods as a result of a reversed shear response may change the transport and behavior of leukocytes in the microcirculation. As leukocytes in a spherical state are frequently larger than typical capillary lumen diameters, leukocytes need to change their shape to pass through most capillary networks. Therefore, their deformability is a key determinant for normal passage through the microcirculation [4 , 14 ]. Pseudopods are relatively rigid structures that exhibit reduced viscoelastic creep compared with the cytoplasm away from pseudopods [4 , 14 ]. Continued shear application leads to a passive spherical shape without pseudopods, which results in increased cell deformability. Thus, an elevated number of leukocytes with pseudopods as a result of attenuated shear response may compromise normal leukocyte passage through capillaries, leading to enhanced microvascular resistance and even capillary occlusion [4 , 14 15 16 17 ].


    ACKNOWLEDGEMENTS
 
NIH Grants HL-10881 and HL-43026 supported this research. We thank Drs. Shunichi Usami and Jeff Price in our department for valuable suggestions.

Received October 8, 2003; revised November 16, 2003; accepted December 14, 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Moazzam, F., Delano, F. A., Zweifach, B. W., Schmid-Schönbein, G. W. (1997) The leukocyte response to fluid stress Proc. Natl. Acad. Sci. USA 94,5338-5343[Abstract/Free Full Text]
  2. Fukuda, S., Yasu, T., Predescu, D. N., Schmid-Schönbein, G. W. (2000) Mechanisms for regulation of fluid shear stress response in circulating leukocytes Circ. Res. 86,E13-E18
  3. Fukuda, S., Schmid-Schönbein, G. W. (2002) Centrifugation attenuates the fluid shear response of circulating leukocytes J. Leukoc. Biol. 72,133-139[Abstract/Free Full Text]
  4. Worthen, G. S., Schwab, B., III, Elson, E. L., Downey, G. P. (1989) Cellular mechanics of stimulated neutrophils: stiffening of cells induces retention in pores in vitro and lung capillaries in vivo Science 245,183-185[Abstract/Free Full Text]
  5. Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F., Weissmann, G. (1992) A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 Proc. Natl. Acad. Sci. USA 89,9991-9995[Abstract/Free Full Text]
  6. Filep, J. G., Delalandre, A. D., Payette, Y., Földes-Filep, E. (1997) Glucocorticoid receptor regulates expression of L-selection and CD11CD18 on human neutrophils Circulation 96,295-301[Abstract/Free Full Text]
  7. Grynkiewicz, G., Poenie, M., Tsien, R. Y. (1985) New generation of Ca2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260,3440-3450[Abstract/Free Full Text]
  8. Mancuso, F., Flower, R. J., Perretti, M. (1995) Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule.Involvement of endogenous lipocortin 1 J. Immunol. 155,377-386[Abstract]
  9. McEwen, B. S. (1991) Non-genomic and genomic effects of steroids on neural activity Trends Pharmacol. Sci. 12,141-147[CrossRef][Medline]
  10. Kornel, L., Nelson, W. A., Manisundaram, B., Chigurupati, R., Hayashi, T. (1993) Mechanism of the effects of glucocorticoids on vascular smooth muscle contractility Steroids 58,580-587[CrossRef][Medline]
  11. Cohen, P. (1988) Protein phosphorylation and hormone action Proc. R. Soc. Lond. (Biol.) 234,115-144[Medline]
  12. Ruiz-Velasco, V., Zhong, J., Hume, J. R., Keef, K. D. (1998) Modulation of Ca2+ channels by cyclic nucleotide cross activation of opposing protein kinases in rabbit portal vein Circ. Res. 82,557-565[Abstract/Free Full Text]
  13. Shih, Y-L., Chou, S-C., Chi, C-W., Tchen, T. T., Lo, S. J. (1990) Tropic effect of dexamethasone on goldfish melanocytoma cells: induction of calcium-dependent but protein synthesis-independent morphological changes Life Sci. 47,313-318[CrossRef][Medline]
  14. Harris, A. G., Skalak, T. C. (1993) Leukocyte cytoskeletal structure determines capillary plugging and network resistance Am. J. Physiol. 265,H1670-H1675
  15. Braide, M., Sonander, H., Johansson, B. R., Bagge, U. (1989) Leukocyte effects on microcirculation in artificially perfused rat lung Am. J. Physiol. 256,H1117-H1126
  16. Eppihimer, M. J., Lipowsky, H. H. (1996) Effect of leukocyte-capillary plugging on the resistance to flow in the microvasculature of cremaster muscle for normal and activated leukocytes Microvasc. Res. 51,187-201[CrossRef][Medline]
  17. Sutton, D. W., Schmid-Schönbein, G. W. (1992) Elevation of organ resistance due to leukocyte perfusion Am. J. Physiol. 262,H1646-H1650



This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Fukuda, T. Yasu, N. Kobayashi, N. Ikeda, and G. W. Schmid-Schonbein
Contribution of Fluid Shear Response in Leukocytes to Hemodynamic Resistance in the Spontaneously Hypertensive Rat
Circ. Res., July 9, 2004; 95(1): 100 - 108.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1003464v1
75/4/664    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, S.
Right arrow Articles by Schmid-Schönbein, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, S.
Right arrow Articles by Schmid-Schönbein, G. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS